Thromboelastography (TEG) Point-of-Care Diagnostic for Hemostasis Management

Point of Care

Volumn 17, Issue 1, 2018, Pages 15-22

  Hartmann, Jan ^a   Mason, Dan ^a   Achneck, Hardean ^a  

^a HAEMONETICS CORPORATION   (United States)

Author keywords

hemostasis; point of care; TEG; thromboelastography; viscoelastic testing

Indexed keywords

EID: 85042844471     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0000000000000156     Document Type: Review

References (64)

1. Gonzalez E, Moore EE, Moore HB, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263(6):1051-1059.
2. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117(3): 531-547.
3. National Institute for Health and Care Excellence (NICE). Detecting, managing and monitoring haemostasis: viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems). NICE Diagnostics Guidance. 2014:1-60. Available at: https://www.nice.org.uk/guidance/dg13/resources/detecting-managing-and-monitoring-haemostasisviscoelastometric-pointofcare-testing-rotem-teg-and-sonoclot-systemspdf-1053628110277. Accessed September 15, 2017.
4. American College of Surgeons. Massive transfusion in trauma guidelines. 2013. Available at: https://www.facs.org/~/media/files/quality%20programs/trauma/tqip/massive%20transfusion%20in%20trauma%20guildelines.ashx. Accessed September 15, 2017.
5. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015;122(2):241-275.
6. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einemneuen Untersuchungs verfahren. Klin Wochenschr. 1948;26(37-38):577-583.
7. Hans GA, Besser MW. The place of viscoelastic testing in clinical practice. Br J Haematol. 2016;173(1):37-48.
8. Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89(2):228-232.
9. Dirkmann D, Görlinger K, Dusse F, et al. Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: a step towards earlier decision making. Acta Anaesthesiol Scand. 2013;57(5):594-603.
10. Fluger I, Maderova K, Simek M, et al. Comparison of functional fibrinogen assessment using thromboelastography with the standard von Clauss method. Biomed PapMed Fac Univ Palacky Olomouc Czech Repub. 2012; 156(3):260-261.
11. Harr JN, Moore EE, Ghasabyan A, et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock. 2013;39(1):45-49.
12. Meyer MA, Ostrowski SR, Sørensen AM, et al. Fibrinogen in trauma, an evaluation of thrombelastography and rotational thromboelastometry fibrinogen assays. J Surg Res. 2015;194(2):581-590.
13. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476-486.
14. Shafi H, Tcherniantchouk O, Chaffin DJ, et al. Transfusion medicine illustrated. Thromboelastography: a more accurate assessment of global hemostasis. Transfusion. 2013;53(11):2605.
15. Moore HB, Moore EE, Chin TL, et al. Activated clotting time of thrombelastography (T-ACT) predicts early postinjury blood component transfusion beyond plasma. Surgery. 2014;156(3):564-569.
16. Chitlur M, Sorensen B, Rivard GE, et al. Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia. 2011;17(3):532-537.
17. Hagemo JS, Næss PA, Johansson P, et al. Evaluation of TEG(®) and RoTEM(®) inter-changeability in trauma patients. Injury. 2013;44(5):600-605.
18. Gonzalez E, Moore EE, Moore HB, et al. Trauma-induced coagulopathy: an institution's 35 year perspective on practice and research. Scand J Surg. 2014;103(2):89-103.
19. Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma. 2011;71(2):407-414.
20. Cotton BA, Minei KM, Radwan ZA, et al. Admission rapid thrombelastography predicts development of pulmonary embolism in trauma patients. J Trauma Acute Care Surg. 2012;72(6):1470-1475.
21. Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252 (3):434-442; discussion 43-4.
22. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
23. Binz S, McCollester J, Thomas S, et al. CRASH-2 study of tranexamic acid to treat bleeding in trauma ppatients: a controversy fueled by science and social media. J Blood Transfus. 2015;2015:874920.
24. Moore HB, Moore EE, Gonzalez E, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77(6):811-817.
25. Dias JD, Norem K, Doorneweerd DD, et al. Use of thromboelastography (TEG) for detection of new oral anticoagulants. Arch Pathol Lab Med. 2015;139(5):665-673.
26. Bowry R, Fraser S, Archeval-Lao JM, et al. Thrombelastography detects the anticoagulant effect of rivaroxaban in patientswith stroke. Stroke. 2014; 45(3):880-883.
27. Bliden KP, Chaudhary R, Mohammed N, et al. Determination of non-vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis. 2017;43(4): 437-445.
28. Connolly SJ, Gibson CM, Crowther M. Andexanet alfa for factor Xa inhibitor reversal. N Engl JMed. 2016;375(25):2499-2500.
29. Pollack CVJr, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal-full cohort analysis. N Engl JMed. 2017;377(5):431-441.
30. Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34(6): 332-395.
31. Agarwal S, Johnson RI, Shaw M. Preoperative point-of-care platelet function testing in cardiac surgery. J Cardiothorac Vasc Anesth. 2015; 29(2):333-341.
32. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg. 2009;24(4):404-410.
33. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography-guided transfusion algorithmreduces transfusions in complex cardiac surgery. Anesth Analg. 1999;88(2):312-319.
34. Raghavan R, Benzaquen BS, Rudski L. Timing of bypass surgery in stable patients after acute myocardial infarction. Can J Cardiol. 2007;23(12): 976-982.
35. Gurbel PA, Bliden KP, Navickas IA, et al. Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-termpoststenting ischemic events. Am Heart J. 2010;160(2):346-354.
36. Preisman S, Kogan A, Itzkovsky K, et al. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg. 2010;37(6):1367-1374.
37. Tantry US, Bonello L, Aradi D, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62(24): 2261-2273.
38. Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev. 2013;27(4):213-220.
39. Fabbro M II, Gutsche JT, Miano TA, et al. Comparison of thrombelastography-derived fibrinogen values at rewarming and following cardiopulmonary bypass in cardiac surgery patients. Anesth Analg. 2016; 123(3):570-577.
40. Galeone A, Rotunno C, Guida P, et al. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27(5):853-858.
41. Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol. 2005;46(10):1820-1826.
42. Von Kaulla KN, Kaye H, von Kaulla E, et al. Changes in blood coagulation. Arch Surg. 1966;92(1):71-79.
43. Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World J Gastroenterol. 2014;20(20):6146-6158.
44. Mallett SV, Chowdary P, Burroughs AK. Clinical utility of viscoelastic tests of coagulation in patientswith liver disease. Liver Int. 2013;33(7):961-974.
45. Kettner SC, Gonano C, Seebach F, et al. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg. 1998;86(4):691-695.
46. De Pietri L, Bianchini M, Rompianesi G, et al. Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation. World J Transplant. 2016;6(3):583-593.
47. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth. 2014;23(1):10-17.
48. Rai R, Tuddenham E, Backos M, et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod. 2003;18(12): 2540-2543.
49. Karlsson O, Sporrong T, Hillarp A, et al. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg. 2012;115(4):890-898.
50. Collins P, Abdul-Kadir R, Thachil J, et al. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(1):205-210.
51. Jámbor C, Kozek-Langenecker SA, Frietsch T, et al. Thrombelastography should be included in the algorithm for the management of postpartum hemorrhage. Transfus Med Hemother. 2008;35(5):391-392.
52. Chitlur M, Rivard GE, Lillicrap D, et al. Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(1):103-106.
53. Chitlur M, Young G. Global assays in hemophilia. Semin Hematol. 2016; 53(1):40-45.
54. Nogami K. The utility of thromboelastography in inherited and acquired bleeding disorders. Br J Haematol. 2016;174(4):503-514.
55. Chitlur M, Warrier I, Rajpurkar M, et al. Thromboelastography in children with coagulation factor deficiencies. Br J Haematol. 2008;142(2): 250-256.
56. Young G, Sørensen B, Dargaud Y, et al. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood. 2013;121(11):1944-1950.
57. Hartmann J, Croteau SE. 2017 Clinical trials update: innovations in hemophilia therapy. Am J Hematol. 2016;91(12):1252-1260.
58. Hilden I, Lauritzen B, Sørensen BB, et al. Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Blood. 2012;119(24):5871-5878.
59. Kawano-Castillo J, Ward E, Elliott A, et al. Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement. Stroke. 2014;45(3):683-688.
60. Elliott A, Wetzel J, Roper T, et al. Thromboelastography in patients with acute ischemic stroke. Int J Stroke. 2015;10(2):194-201.
61. Rowe AS, Greene CL, Snider CC, et al. Thromboelastographic changes in patients experiencing an acute ischemic stroke and receiving alteplase. J Stroke Cerebrovasc Dis. 2014;23(6):1307-1311.
62. de Villiers S, Swanepoel A, Bester J, et al. Novel diagnostic andmonitoring tools in stroke: an individualized patient-centered precision medicine approach. J Atheroscler Thromb. 2016;23(5):493-504.
63. Yang H, Li Y, Jiang Y, et al. Thromboelastography for monitoring platelet function in unruptured intracranial aneurysm patients undergoing stent placement. Interv Neuroradiol. 2015;21(1):61-68.
64. Gurbel PA, Bliden KP, Tantry US, et al. First report of the point-of-care TEG: a technical validation study of the TEG-6S system. Platelets. 2016; 27(7):642-649.